Skip to content
    HonorHealth logo

    HonorHealth

    Scottsdale, Arizona, United StatesFounded 1927

    HonorHealth is a nonprofit integrated healthcare system headquartered in Scottsdale, Arizona, and one of the largest in the state. Its innovation and investment arm, HonorHealth Innovations (H2I), focuses on accelerating breakthrough healthcare solutions and investing in healthcare startups.

    60% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (40% of deals). Average disclosed round size is $27.5M (across 5 rounds with reported amounts).

    Find people at HonorHealth on Goldilocks AI

    Portfolio

    3

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    JW

    Jim Whitfill, MD

    Senior vice president, strategic partnerships and chief transformation officer

    KP

    Kim Post

    Executive vice president, chief operations officer

    LE

    Lisa E. Montman

    Executive vice president, chief financial officer

    NS

    Nina Shah

    Senior vice president, chief medical officer

    RK

    Riana Kielly, MSN, BSN, RN, NE-BC

    Senior vice president, service line integration, perioperative & procedural care

    SF

    Shannon Fox Fraser

    Senior vice president and general counsel

    WF

    Wayne Frangesch

    Senior vice president, chief human resources officer

    KJ

    Kathryn Jo Lincoln

    Chief Investment Officer of the Lincoln Institute of Land Policy

    CM

    Charles Mitchell, Jr

    CEO and co-founder

    HJ

    Heidi Jannenga, PT, DPT, ATC

    co-founder and chief clinical officer of WebPT

    AS

    Alpa Shah, MD, FCCP

    Board of Directors

    AK

    Andrew Kassir, MD, FACS, FASCRS, FRCSI

    president of the Colon & Rectal Clinic of Scottsdale

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    CND Life Sciences logoCND Life SciencesSeries A$13.5MMay 2025
    Qventus logoQventusSeries D$105MJan 2025
    Altoida logoAltoidaSeries A$14MJan 2024
    CND Life Sciences logoCND Life SciencesSeed$2.4MMar 2021
    CND Life Sciences logoCND Life SciencesSeed$2.4MJan 2021

    Top Co-Investors

    Last updated: 27 September 2026